Clinical Trial Update: GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of GM-CSF with Rituximab in previously untreated follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• sargramostim (sargramostim)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN